Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: Design, characterization and in vivo evaluation

International Journal of Pharmaceutics

Volumn 439, Issue 1-2, 2012, Pages 349-357

  Han, Fei ^a   Yin, Ran ^a   Che, Xin ^a   Yuan, Jing ^a   Cui, Yanan ^a   Yin, He ^a   Li, Sanming ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Flurbiprofen; Nanostructured lipid carriers; Pharmacodynamic; Pharmacokinetic; Topical gel

Indexed keywords

CARBOMER; DRUG CARRIER; FLURBIPROFEN; NANOMATERIAL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; COLLOID; CONTROLLED STUDY; DISPERSION; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG PENETRATION; EDEMA; ERYTHEMA; EXPERIMENTAL RABBIT; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; PARTICLE SIZE; PAW EDEMA; PRIORITY JOURNAL; RAT; SKIN; SKIN TEST; STORAGE TEMPERATURE; THIXOTROPY; X RAY ANALYSIS; ZETA POTENTIAL;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG CARRIERS; EDEMA; FATTY ACIDS; FLURBIPROFEN; GELS; MALE; NANOSTRUCTURES; OVALBUMIN; PARTICLE SIZE; RATS; RATS, WISTAR; SKIN; SKIN ABSORPTION; SKIN IRRITANCY TESTS; SURFACE-ACTIVE AGENTS; TRIGLYCERIDES;

EID: 84869507147     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.08.040     Document Type: Article

References (42)

1. A.M. Barbero, and H.F. Frasch Pig and guinea pig skin as surrogates for human in vitro penetration studies: a quantitative review Toxicol. In Vitro 23 2009 1 13
2. K. Bhaskar, J. Anbu1, V. Ravichandiran1, and V. Venkateswarlu Lipid nanoparticles for transdermal delivery of flurbiprofen: formulation, in vitro, ex vivo and in vivo studies Lipids Health Dis. 8 2009 6
3. I.P. Dick, and R.C. Scott Pig ear skin as an in-vitro model for human skin permeability J. Pharm. Pharmacol. 44 1992 640 645
4. J. Draize, G. Woodard, and H. Calvery Methods for the study of irritation and toxicity of substances topically applied to skin and mucous membranes J. Pharmacol. Exp. Ther. 82 1944 377 390
5. Effing, J.J.; Gruhlk, E.A.; Godbey, K.J.; Welsing, W.; 1997. Transdermal device for the delivery of flurbiprofen. Patent: W009733205-A.1997.1.3.
6. J.Y. Fang, K.C. Sung, H.H. Lin, and C.L. Fang Transdermal iontophoretic delivery of diclofenac sodium from various polymer formulations: in vitro and in vivo studies Int. J. Pharm. 178 1999 83 92
7. J.Y. Fang, C.L. Fang, C.H. Liu, and Y.H. Su Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC) Eur. J. Pharm. Biopharm. 70 2008 633 640
8. B. Godin, and E. Touitou Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models Adv. Drug Deliv. Rev. 59 2007 1152 1161
9. C.Y. Guo, C.F. Yang, Q.L. Li, Q. Tan, Y.W. Xi, W.N. Liu, and G.X. Zhai Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery Int. J. Pharm. 430 2012 292 298
10. F. Han, S.M. Li, R. Yin, X.L. Shi, and Q. Jia Investigation of nanostructured lipid carriers for transdermal delivery of flurbiprofen Drug Dev. Ind. Pharm. 34 2008 453 458
11. M.T. Islam, N. Rodríguez-Hornedo, and S. Ciotti Rheological characterization of topical carbomer gels neutralized to different pH Pharm. Res. 21 2004 1192 1199
12. V. Jenning, A. Gysler, M. Schafer-Korting, and S.H. Gohla Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin Eur. J. Pharm. Biopharm. 49 2000 211 218
13. V. Jenning, M. Schafer-Korting, and S. Gohla Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties J. Control. Release 66 2000 115 126
14. M.D. Joshi, and V.B. Patravale Formulation and evaluation of nanostructured lipid carrier (NLC) based gel of valdecoxib Drug Dev. Ind. Pharm. 32 2006 911 918
15. V.B. Junyaprasert, V. Teeranachaideekul, E.B. Souto, P. Boonme, and R.H. Müller Q10-loaded NLC versus nanoemulsions: stability, rheology and in vitro skin permeation Int. J. Pharm. 377 2009 207 214
16. H. Kitagawa, T. Sakai, H. Saito, M. Mori, R. Tazoe, T. Sugibayashi, and A. Nomura Anti-inflammatory and analgesic actions and skin irritation of flurbiprofen by dermal application Iyakuhin Kenkyu 13 1993 869 878
17. K. Kyuki, K. Tsurumi, H. Fujimura, S. Masumoto, and Y. Hashimoto Anti-inflammatory effect of flurbiprofen for dermal application (FP-A) Iyakuhin Kenkyu 15 1984 293 298
18. C.H. Lee, V. Moturi, and Y. Lee Thixotropic property in pharmaceutical formulations J. Control. Release 136 2009 88 98
19. 19F magnetic resonance spectroscopy J. Invest. Dermatol. 99 1992 431 434
20. M.Y. Levy, W. Schutze, C. Fuhrer, and S. Benita Characterization of diazepam submicron emulsion interface: role of oleic acid J. Microencapsul. 11 1994 79 92
21. A. Lippacher, R.H. Muller, and K. Mader Liquid and semisolid SLN dispersions fortopical application: rheological characterization Eur. J. Pharm. Biopharm. 58 2004 561 567
22. W. Liu, M. Hu, C. Xue, H. Xu, and X. Yang Investigation of the carbopol gel of solid lipid nanoparticles for the transdermal iontophoretic delivery of triamcinoloneacetonide acetate Int. J. Pharm. 364 2008 135 141
23. S. Masumoto, T. Akiba, M. Okumura, K. Ichikawa, and Y. Hashimoto Anti-inflammatory effect of flurbiprofen by topical application Iyakuhin Kenkyu 13 1982 878 885
24. S.C. McNeill, R.O. Potts, and M.L. Francoeur Local enhanced topical delivery (LETD) of drugs: does it truly exist? Pharm. Res. 9 1992 1422 1427
25. R.H. Müller, M. Radtke, and S.A. Wissing Nanostructured lipid matrices for improved microencapsulation of drugs Int. J. Pharm. 242 2002 121 128
26. J. Pardeike, A. Hommoss, and R.H. Müller Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products Int. J. Pharm. 366 2009 170 184
27. J. Pardeike, K. Schwabea, and R.H. Müller Influence of nanostructured lipid carriers (NLC) on the physical properties of the Cutanova Nanorepair Q10 cream and the in vivo skin hydration effect Int. J. Pharm. 396 2010 166 173
28. S.R. Patel, H. Zhong, A. Sharma, and Y.N. Kalia In vitro and in vivo evaluation of the transdermal iontophoretic delivery of sumatriptan succinate Eur. J. Pharm. Biopharm. 66 2007 296 301
29. J. Poul, J. West, N. Buchanan, and R. Grahame Local action transcutaneous flurbiprofen in the treatment of soft tissue rheumatism Br. J. Pharmacol. 32 1993 1000 1003
30. C. Sajeev, P.R. Jadhav, D. RaviShankar, and R.N. Saha Determination of flurbiprofen in pharmaceutical formulations by UV spectrophotometry and liquid chromatography Anal. Chim. Acta 463 2002 207 217
31. K. Sato, K. Sugibayashi, and Y. Morimoto Species differences in percutaneous absorption of nicorandil J. Pharm. Sci. 80 1991 104 107
32. A. Saupe, K.C. Gordon, and T. Rades Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopy Int. J. Pharm. 314 2006 56 62
33. N. Seetapan, P. Bejrapha, W. Srinuanchai, and U.R. Ruktanonchai Rheological and morphological characterizations on physical stability of gamma-oryzanol-loaded solid lipid nanoparticles (SLNs) Micron 41 2010 51 58
34. K.A. Shah, A.A. Date, M.D. Joshi, and V.B. Patravale Solid lipid nanoparticles (SLN)of tretinoin: potential in topical delivery Int. J. Pharm. 345 2007 163 171
35. E.B. Souto, S.A. Wissing, C.M. Barbosa, and R.H. Muller Evaluation of the physical stability of SLN and NLC before and after incorporation into hydrogel formulations Eur. J. Pharm. Biopharm. 58 2004 83 90
36. E.B. Souto, S.A. Wissing, C.M. Barbosa, and R.H. Müller Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery Int. J. Pharm. 278 2004 71 77
37. J.P. Sylvestre, R.H. Guy, and M.B. Delgado-Charro In vitro optimization of dexamethasone phosphate delivery by iontophoresis Phys. Ther. 88 2008 1177 1185
38. T.F. Tadras, and B. Vincent Influence of temperature and electrolytes on the adsorption of poly(ethylene oxide)-poly(propylene oxide) block copolymer on polystryrene latex and on the stability of the polymer coated particles J. Phys. Chem. 84 1980 1575 1582
39. V. Teeranachaideekul, P. Boonme, E.B. Souto, R.H. Müller, and V.B. Junyaprasert Influence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLC J. Control. Release 128 2008 134 141
40. B.J. Verneer Skin irritation and sensitization J. Control. Release 15 1991 261 265
41. S.A. Wissing, A. Lippacher, and R.H. Müller Investigations on the occlusive properties of solid lipid nanoparticles (SLN) J. Cosmet. Sci. 52 2001 313 323
42. Y. Yue, H.F. Zhou, G.L. Liu, Y. Li, Z.M. Yan, and M.X. Duan The advantages of a novel CoQ10 delivery system in skin photo-protection Int. J. Pharm. 392 2010 57 63